Omeprazole Drug Review: PTCB Exam Must-Know Facts

Omeprazole Overview for Pharmacy Technicians

Omeprazole is one of the most widely used over-the-counter and prescription medications in the United States. As a proton pump inhibitor (PPI), it is a foundational drug for the PTCB certification exam. This review covers everything you need to know about omeprazole for your 90-question exam at Pearson VUE.

Brand Name and Classification

Omeprazole is sold under the brand name Prilosec (OTC and prescription). A combination product with sodium bicarbonate is available as Zegerid. Omeprazole belongs to the proton pump inhibitor (PPI) class, identified by the suffix -prazole. Other PPIs include esomeprazole (Nexium), lansoprazole (Prevacid), pantoprazole (Protonix), and rabeprazole (Aciphex).

Mechanism of Action

Omeprazole irreversibly inhibits the hydrogen-potassium ATPase pump (proton pump) on the parietal cells of the stomach. This blocks the final step of acid secretion, reducing gastric acid production by up to 90%. Because the inhibition is irreversible, new proton pumps must be synthesized before acid secretion resumes, which is why the effect lasts longer than the drug's half-life.

Common Indications

Gastroesophageal reflux disease (GERD): First-line treatment
Peptic ulcer disease: Duodenal and gastric ulcers
Helicobacter pylori eradication: Used in combination with antibiotics
Zollinger-Ellison syndrome: Pathological hypersecretory conditions
NSAID-induced ulcer prevention: Protective therapy for chronic NSAID users

Dosing Information

Omeprazole is available in 10 mg, 20 mg, and 40 mg delayed-release capsules. The typical dose for GERD is 20 mg once daily for 4 to 8 weeks. For H. pylori eradication, the dose is typically 20 mg twice daily combined with antibiotics. OTC omeprazole is 20 mg and intended for 14-day courses. The medication should be taken 30 to 60 minutes before a meal, preferably in the morning.

Side Effects

Headache: Most commonly reported adverse effect
Diarrhea and nausea: GI effects are generally mild
Vitamin B12 deficiency: With long-term use due to reduced acid-dependent absorption
Magnesium deficiency: Hypomagnesemia with prolonged use
Bone fracture risk: FDA warning with long-term, high-dose use
Clostridium difficile infection: Increased risk with acid suppression

Drug Interactions

Clopidogrel: Omeprazole inhibits CYP2C19, reducing clopidogrel activation; this is a critical PTCB exam interaction
Methotrexate: PPIs may increase methotrexate levels
Iron, calcium, and magnesium supplements: Reduced absorption due to decreased stomach acid
Diazepam and phenytoin: Omeprazole may increase their levels via CYP inhibition

PTCB Exam Tips

Remember: omeprazole is brand Prilosec, PPIs end in -prazole, they should be taken before meals, and the critical interaction with clopidogrel is high-yield. Long-term PPI risks (B12 deficiency, fractures, C. difficile) are also tested. Know the difference between PPIs and H2 blockers (famotidine, ranitidine).

Solidify your drug knowledge at PTCBprep flashcards and challenge yourself with our timed practice exams.